Oncology Review article High-Resolution MRI in Rectal Cancer

Size: px
Start display at page:

Download "Oncology Review article High-Resolution MRI in Rectal Cancer"

Transcription

1 Oncology Review article High-Resolution MRI in Rectal Cancer Adriana Dieguez Department Of Magnetic Resonance And Computed Tomography In Oncologic Diseases, Diagnóstico Médico Junín 1023, C1113AAE. Buenos Aires, Argentina. ( Abstract High-resolution MRI is the best method of assessing the relation of the rectal tumor with the potential circumferential resection margin (CRM). Therefore it is currently considered the method of choice for local staging of rectal cancer. The primary surgery of rectal cancer is total mesorectal excision (TME), which plane of dissection is formed by the mesorectal fascia surrounding mesorectal fat and rectum. This fascia will determine the circumferential margin of resection. At the same time, high resolution MRI allows adequate pre-operative identification of important prognostic risk factors, improving the selection and indication of therapy for each patient. This information includes, besides the circumferential margin of resection, tumor and lymph node staging, extramural vascular invasion and the description of lower rectal tumors. All these should be described in detail in the report, being part of the discussion in the multidisciplinary team, the place where the decisions involving the patient with rectal cancer will take place. The aim of this study is to provide the information necessary to understand the use of high resolution MRI in the identification of prognostic risk factors in rectal cancer. The technical requirements and standardized report for this study will be describe, as well as the anatomical landmarks of importance for the total mesorectal excision (TME), as we have said is the surgery of choice for rectal cancer. Key Words: Rectal cancer; High - resolution magnetic resonance imaging; Circumferential resection margin; Multidisciplinary team; Prognostic risk factors Introduction Colorectal cancer ranks third amongst the most frequently diagnosed tumors in the world, after lung cancer and breast cancer (1). It ranks third in women and fourth in men (1,2). Currently, rectal cancer is handled by a multidisciplinary team (MDT), thus allowing the best diagnosis and treatment options to the patient. It is here where radiologists are confronted with a big challenge, which lies in the importance that our support has within the MDT, since the adequate staging allows proper treatment selection. Active participation in these meetings offers the possibility of continuous exchange between colleagues (oncologists, surgeons, radiotherapists, gastroenterologists, etc.), who will audit our work. We should stress that diagnostic and therapeutic success are directly related with obtaining free margins in histopathology, the so-called circumferential resection margin. High-resolution MRI is the best method of assessing the relation of the tumor to the potential circumferential resection margin: the mesorectal fascia (3). Total mesorectal excision (TME) is the primary surgery for rectal cancer. The dissection plane is formed by the mesorectal fascia that surrounds the mesorectal fat and rectum (4).

2 This fascia determines the circumferential resection margin (Fig.1). The presence of tumor at 1 mm or less from the fascia is directly related with local recurrence and a poor survival rate. While TME cures early stages of the disease, preoperative radiotherapy or chemoradiotherapy provide tumor size and staging reduction in most extensive disease, increasing the possibility of attaining free margins in surgery. Traditionally, surgeons evaluated rectal cancer patients using digital examination, endorectal ultrasound and, in some cases, computed tomography. These methods do not provide the information necessary concerning the relation of the tumor with the circumferential resection margin, which we can access today through high-resolution MRI. As principal benefits, adequate staging by high-resolution MRI avoids unnecessary preoperative treatments, provides an objective staging system for future clinical trials and allows the selection of the best possible preoperative therapy for the patients that need it (3). Technique The high spatial resolution sequences permit a better morphological analysis of the images, a fundamental characteristic for the evaluation of the different prognostic risk factors that we must identify. As with all diagnostic studies that use images, this one is supported by two fundamental pillars: the proper technique and the correct interpretation, which in this case requires trained radiologists. Sometimes intestinal peristalsis degrades the quality of the high-resolution images, impeding an adequate interpretation. For this reason we have implemented in our center a preparation the patient must accomplish before the exam: 1) two days before the exam: 2 pills of simethicone 200mg after each meal (8 pills a day); 2) during those 2 days: avoid meals that contain flour and green-leaf vegetables; 3) the day of the exam: 2 pills of simethicone 200mg 2 hours before the MRI; 4) 8 hours of fasting The exploration time is prolonged, which should be communicated to the patient. A phased-array coil is used, thus improving the signal and providing greater exploration surface for the ETM when compared to the endorectal coil, which is already in disuse for rectal cancer local staging. The images shown in this paper were made using 1.5T equipment (Signa Horizon LX, GE Medical System, Milwaukee, Wisconsin, USA). The rectal cancer staging protocol consists of T2 weighted images (Table 1), in the 3 planes (Fig. 2): sagittal (following the inferior rectal axis and anal canal of the locator), axial (perpendicular to the rectum at the site of the tumor in the high-resolution sagittal images obtained in first place) and, in tumors in the inferior rectum, concluding with the coronal plane (parallel to the anal canal in the high-resolution sagittal images). The study of the pelvis is completed with the evaluation of the retroperitoneal space (to evaluate ascendant and lateral lymphatic dissemination) and of the hepatic gland (to determine the presence of metastasis and the possibility of resection) (Tables 2 and 3). We complete the rectal cancer staging with a helical computed tomography of the chest without endovenous contrast, for the identification of secondary lesions of the lungs.

3 Preoperative Staging of Rectal Cancer As we have already mentioned, rectal cancer is a disease addressed by a multidisciplinary team compromised of, amongst others, surgeons, oncologists, radiotherapists, radiologists and pathologists. Discussion within the multidisciplinary team of the findings of the high-resolution MRI and of the preoperative therapeutic strategy is fundamental given that it significantly reduces the positive circumferential resection margin in rectal cancer patients (5). Within this multidisciplinary task, the fundamental contribution of the radiologist lies in determining if the circumferential resection margin is free or compromised, this way acquiring, through the high-resolution MRI, an important role and, therefore, a great responsibility in the handling of the rectal cancer patient. As Dr. Nagtegaal and Dr. Quirke (6) conclude: In the current era, when evidence-based medicine and quality control are keywords, we believe that the best practice demands the reporting of circumferential resection margin by radiologists and pathologists alike. Therefore, this information should always be present in the high-resolution MRI report, keeping in mind that therapeutic success is directly related with the achievement of free margins in the histopathology. Patients with involved circumferential resection margin should be identified prior to surgery, as they will be selected to receive neoadjuvant therapy. A radiologist trained in the interpretation of high-resolution MRI of rectal cancer patients must be conscious of the responsibility this medical procedure entails. Over-staging implies performing unnecessary therapies, while under-staging requires postoperative combined treatment, generally accompanied with worse functional results, greater toxicity and less local control. In prognostic terms, patients with positive circumferential resection margin show local recurrence at 5 years in approximately 23.7% of cases and disease-free survival at 5 years in approximately 44.5% of cases. In contrast, patients with negative circumferential resection margin have a rate of local recurrence at 5 years of approximately 8.9% and disease-free survival at 5 years at a rate of 66.7% (7). Once the study is finished, we must identify the prognostic risk factors in rectal cancer, knowing that they will be taking into account for the correct choice of treatment. Consequently, we should state with precision the following information: 1) depth of extramural spread in T3 tumors; 2) peritoneal involvement; 3) increasing percentage of nodal disease; 4) extramural vascular invasion; 5) Full thickness T2 or more at the level of puborectal muscle. 1) Tumor Staging The principal purpose of the high-resolution MRI in rectal cancer tumor staging is to determine the extramural extension in T3 tumors and the involvement of neighboring organs in T4. For superficial tumors, endorectal ultrasound has higher accuracy in the evaluation of parietal involvement (8). The seventh edition of the TNM classification of rectal cancer, effective as of January 2010, has presented changes in tumor staging (T), specifically in T4 (9) (Table 4). In T3, the tumor invades the subserosa through the muscularis propria. We assign the term extramural depth of tumor invasion to the distance between the lateral border of the longitudinal muscular layer of the muscularis propria and the lateral border of the tumor (Fig. 3). The measurement of the extramural depth of the tumor by high-resolution MRI is equivalent to the corresponding measurement in the histological analysis (10). In accordance with the extramural depth of the tumors, the T3 is divided into: T3a (<1mm), T3b (1.01-5mm), T3c ( mm) and T3d (>15mm) (10,11). This

4 distance is important for a proper therapeutic choice. Five years survival rate after surgery for patients with extramural depth greater than 5 mm is 54%, while for those patients with a maximum depth less than 5 mm it is 85% (10). In the tumors of the upper-third and upper-half it is of the utmost importance to seek the relation with the peritoneal reflection and its possible compromise, in which case we are speaking of T4a staging (Fig. 4). Involvement of the bladder and uterus must also be ruled out in high tumors. In middle third tumors and below in men, an invasion of the prostate and seminal vesicles may occur, or of the cervix and uterine body in women. Lateral extension may compromise the pelvic wall and the posterior the sacrum. When the tumor invades other organs and structures in the high-resolution MRI images, we speak of T4b staging, having this worse diagnosis. 2) Lymph Node Staging The lymphatic dissemination of rectal cancer can follow an ascendant path, a lateral (uni- or bilateral) path, or a combination of the two. Ascending path presents pararectal dissemination along the superior rectal and inferior mesenteric arteries. The lateral dissemination occurs towards the middle rectal, obturator, external iliac and internal iliac arteries. It is necessary to analyze in detail the probable paths of dissemination keeping in mind that low rectal tumors have a greater tendency to disseminate laterally. Just like in tumor staging, lymph node staging presents modifications in the latest TNM classification (Table 5), subdividing the N1 and N2. It is worth noting that the N3 stopped being used in the previous edition (the sixth), in effect from the year 2002 to december 2009, due to being recategorized. With respect to the criteria employed to evaluate lymph node involvement in rectal cancer, it has been shown that the size of the positive and negative lymph nodes in the mesorectum is similar, with 50% of the positive lymph nodes reaching a diameter less than 5mm. Therefore, if size is considered as sole parameter, the percentage of false positives increases. Gina Brown (12) evaluated lymph node size, the morphology and signal intensity, improving the predictive value of the high-resolution MRI. The border of the evaluated lymph nodes were classified as regular and well-defined or irregular and poorly-defined. In the high-resolution MRI, the lymph nodes with irregular and poorly-defined borders suggest metastatic involvement with a sensibility of 75% and a specificity of 98% (Fig. 5A). The discovery of lymph nodes with mixedsignal intensity (foci of different signal intensity within the lymph node) presents a specificity of 98% in determining metastatic involvement (Fig. 5B). The mixed signal intensity by high-resolution MRI in the lymph nodes correlates with tumor deposits, areas of necrosis or extracellular mucin in the histopathological analysis. Currently USPIO (Ultrasmall Superparamagnetic Iron Oxide Particles) agents are being evaluated to determine lymph node involvement in rectal cancer patients. After administration of the contrast in non-metastatic lymph nodes, central or homogeneous hypointensity is observed. The discovery of lymph nodes with homogeneous or peripheral hyperintensity suggests tumor involvement (13,14). The importance of the information provided by the high-resolution MRI translates for oncologists and radiotherapists into the determination of the type and extension of the neoadjuvant therapy. For surgeons it provides information in relation to the extension of surgical resection. We must keep in mind that the majority of the mesorectal lymph nodes are located in the dorsolateral region, without significant differences in regards to the distribution among positives and negatives. With respect to the height of the tumor, the majority of the positive lymph nodes are found at the same level as the tumor or proximal to the tumor. Positive lymph nodes distal to the tumor are rare, being found in patients with greater numbers of proximal metastases (15). Extramesorectal positive lymph

5 nodes occur with greater frequency in the low rectal cancer, with lymph node involvement in the mesorectum. 3) Extramural Vascular Invasion The term extramural vascular invasion is applied to the presence of tumor cells within blood vessels located outside the intestinal wall, being found in % of colorectal cancer patients (16). High-resolution MRI is useful in the preoperative detection of extramural vascular invasion (Fig. 6). Patients with positive identification by high-resolution MRI have a 3-year disease-free survival of 35%, versus 74% for those with negative identification by high-resolution MRI. It is important to take into consideration that the scoring system of extramural vascular invasion by high-resolution MRI is equivalent to the histology in the prediction of disease-free survival (17) (Fig. 7). Histological extramural vascular invasion is recognized as an independent predictive factor of local and distant recurrence and poorer overall survival (16-18). Classification of extramural vascular invasion by high-resolution MRI is important for the correct preoperative treatment choice and also determines the postoperative surveillance; at the same time, it provides additional staging information, showing vascular invasion that is not recognized in the histopathology. The depth of the tumor invasion indicates the potential of the extramural vascular invasion, being associated with greater pt, pn and, generally, positive circumferential resection margin (16,17). 4) Circumferential Resection Margin When the circumferential resection margin is evaluated by high-resolution MRI, the minimum distance between the tumor and the mesorectal fascia must be measured. It is called involvement of the margin when the tumor is located at a distance of less than 1 mm, is in direct contact, or extends through the mesorectal fascia (11,19) ; the distance between the fascia and the involved lymph nodes also should be included, as well as tumor deposits and extramural vascular invasion. At the present time, the work of the MDT is focused on obtaining free circumferential resection margin, with the goal of avoiding local recurrence (20). We have stated that diagnostic and therapeutic success is directly related with obtaining free margins in the histopathology. Therefore radiologists must identify in the high-resolution MRI images the patients with an involved circumferential resection margin in order to provide them with preoperative treatment. We must not forget that the larger the distance of the tumor from the circumferential resection margin is, the better the prognosis (6,21). In a publication from the Mercury group (3), the specificity of the high-resolution MRI in determining the free circumferential resection margin was 92%. The free circumferential resection margin implies a lower local recurrence rate and greater overall survival (7). 5) Low Rectal Tumors Low rectal tumors are located in the area of the rectum and mesorectum, under the origin of the levator complex, where the mesorectum thins, generally 6 cm from the anal margin. They make up a third of rectal tumors. Due to their anatomical characteristics, rectal tumors at this location are associated with a greater risk of involvement of the circumferential resection margin and anal sphincter. For this reason they imply a therapeutic challenge for the MDT, with the objectives being local control and the preservation of the sphincter. Recent publications incorporated a new staging by highresolution MRI for low rectal tumors, useful in the handling of these patients that differ from those cases of superior and middle localization (Table 6) (11). In these patients it is important to describe the relationship of the tumor with the muscular layer, the levator muscle and the external anal sphincter (Fig. 8). We should also look for the possible extension towards the prostate, the seminal vesicles, the

6 vagina, the sacrum and the coccyx. The high-resolution MRI offers essential information for determining the relationship of the tumor with the anal sphincter and is, at the same time, useful in defining free margins, both distal and circumferential, allowing adequate selection of treatment and surgical technique (22,23). Post Neoadjuvant High-Resolution Magnetic Resonance The high-resolution MRI presents difficulties in differentiating fibrous tissue with or without tumor cells in patients that were treated with chemoradiotherapy (Fig. 9). Consequently, the technique is not capable of differentiating residual microscopic tumor from complete pathological response in a single test, thus requiring a series of high-resolution MRIs for confirmation. Patients that have received neoadjuvant treatment are evaluated using the degree of tumoral regression from Dworak and collaborators (24), adapted to the images (Table 7) (11). The analysis of the degree of regression is a better predictor of outcome after treatment than T stage. High-resolution MRI shows the presence of fibrosis as well as mucin lakes. According to recent publications, specific findings can predict with great precision the invasion or absence of tumor in mesorectal fascia (25). O'Neil and collaborators (26) began a pilot study that researches non-surgical treatment on patients with complete response using modern techniques for identification, including high-resolution MRI. According to the authors, it is the first prospective study in the world with these characteristics. About 25% of the patients present complete pathological response after the neoadjuvant treatment. Considering these findings, the researchers propose, in an adequately-selected group of patients, to avoid surgery, especially in those patients that need definitive colostomy. High-resolution MRI performed 4 and 6 weeks after chemoradiotherapy being finished rarely is normal, even in patients with complete pathological response. Patients with optimal response at high-resolution MRI present scar tissue at the tumor site; nevertheless, cellular composition cannot be determined. Therefore, a single high-resolution MRI cannot diagnose complete response and monitoring with serial studies is required. The authors perform a high-resolution MRI 4 weeks after neoadjuvant treatment has finished, and another after 8 weeks for patients with at least a partial response. With proper patient selection, they implemented a program of control every 3 months with high-resolution MRI, clinical examination and rectosigmoidoscopy during the first year. If desired results are achieved, this will permit large-scale tests, thus establishing the capability of the high-resolution MRI in predicting complete response after neoadjuvant treatment. The Dr. Regina Beets-Tan group (27,28) evaluated the utility of the high-resolution MRI in the restaging of the patient after neoadjuvant treatment, with the objective of predicting tumor confined to the rectal wall, which permits a more personalized therapeutic plan. The results showed a high positive predictive value (91%) of high-resolution MRI for the prediction of tumor circumscribed to the rectal wall (ypt0-t2) after chemoradiotherapy (27). Therefore, restaging with high-resolution MRI following preoperative treatment can be a useful tool in the identification of residual tumor limited to the rectal wall, allowing consideration of transanal local excision for the patients with good response with less morbidity and mortality rates in relation to conventional surgery. It could also be useful in identifying those patients without lymph node involvement, with a positive predictive value of % (28).

7 Radiologist s contribution to the Multidisciplinary Team The MDT will analyze the particular situation of every patient with rectal cancer. With this aim the accomplished examinations will be taken into consideration to determine local staging and probable distant involvement. The findings from digital examination, colonoscopy, endorectal ultrasound and high-resolution MRI will be evaluated. To determine distant involvement, a helical computed tomography of the chest is indicated and for the examination of the abdomen a computed tomography or MRI is used. In accordance with the prognostic risk factors evaluated by the high-resolution MRI and taking into account the clinical case of each particular patient, the correct treatment will be selected, which, according to what has been previously confirmed, could be primary surgery or neoadjuvant treatment, the latter depending on the extramural extension of the tumor, the number of involved lymph nodes, the presence of extramural vascular invasion and the involvement of the circumferential resection margin. As previously explained, low rectal tumors require a detailed analysis to achieve balance between a safe decision in terms of resection margins and quality of life for the patient trying to avoid a permanent colostomy. Therefore, the information that high-resolution MRI offers is of great importance within the MDT and, consequently, the report must be detailed (10,11) (see Table 8. Standardized Report). As a result, it is crucial to conduct a technically correct study, since an extensive and detailed report, in which millimetric differences will be evaluated and considered in the decision of the adequate therapy of each patient, will be needed. The formation of a work team within the MRI service will help the examination be carried out correctly and the training of the technician who performs the exploration and of the radiologist who directs it is fundamental. The presence of the radiologist during the exam is very important in order to be able to accomplish additional sequences, if necessary, this way avoiding a new visit to the MRI room by the patient, with the burden of stress and anguish that usually accompany the oncological patient. The trained radiologist is responsible for the quality of the exploration and should perform the detailed information analysis to later present it to the MDT. From what has been shown here, we can confirm that the time factor is fundamental: time to perform the exam and time for the analysis of the images. Conclusion The ability of high-resolution MRI for showing with precision the mesorectal anatomy has converted this method into a useful tool in rectal cancer staging. It allows identification of prognostic risk factors that will determine the selection of adequate treatment for each patient. Performing a technically optimal study, that respects the parameters of high-resolution and the presence of technicians trained in its procedures and radiologists that supervise the study, are fundamental for an adequate interpretation of the images. Just as important is a detailed report written by dedicated and trained radiologists that participate at the same time in multidisciplinary groups. Teamwork allows exchange of enriching information, of utmost value for the evaluation of the images. Radiologists occupy a very important space within the group, given that the decisions are made based in part on the information that high-resolution MRI offers. On the other hand, it is also a way to audit our work, allowing the correction of errors and the improvement of the quality of our contribution.

8 Fig.1. A. Patient with rectal cancer, 50 year-old man. T2-weighted high-resolution image, axial plane, showing the mesorectal fascia (arrowheads). B. Patient with rectal cancer, 52 year-old man. T2- weighted high-resolution image, axial plane. Involvement of the circumferential resection margin (dotted line) by extension of the primary tumor towards the mesorectal fascia (Hour 4 to Hour 11). Table 1. High-resolution pelvis MRI parameters. T2 FRFSE SAGITAL AXIAL CORONAL TR TE ETL BANDWITH FREQ PHASE FOV 20cm 20cm 20cm SLICE THICKNESS SPACING NEX FREQ DIR A/P A/P S/I AUTO CENTER FREQ WATER WATER WATER SLICE TIME 8:40 13:05 5:38 AUTOSHIM PULSE SEQ FRFSE-XL FRFSE-XL FRFSE-XL IMAGING OPTIONS NPW, SCIC, TRF, FAST, ZIP512 NPW, SCIC, TRF, FAST, ZIP512 NPW, SCIC, TRF, FAST, ZIP512 MODE 2D 2D 2D ADDITIONAL PARAMETERS SATURATION BANDS (SI) SATURATION BANDS (SI) SATURATION BANDS (SI)

9 A B D F C E G Fig. 2. Patient with low rectal cancer, 64 year-old man. In the initial localization images (A and B) the sagittal plane is programmed for viewing the pelvis from the sacral promontory to the anal margin (C). D and E: In the T2-weighted high resolution images obtained in the sagittal plane, the axial plane is programmed, perpendicular to the major axis of the rectum, at the site of the tumor, from the sacral promontory to the anal margin for the viewing of the mesorectum and iliac chains. F and G: Low rectal tumors are completed with the coronal plane, perpendicular to the anal canal, for the evaluation of the sphincter.

10 Table 2. Hepatic evaluation. AX T2 FRFSE RESP COMP FAT SAT AXIAL TE 90 ECHO TRAIN 17 BANDWITH FOV 38 SLICE THICKNESS 4.0 SPACING 0.0 FREQ 256 PHASE 160 NEX 3.00 PHASE FOV 0.75 FREQ DIR R/L AUTO CENTER FREQ WATER FLOW COMP DIRECTION SLICE PLANE OBLIQUE PULSE SEQ FRFSE XL MODE 2D TIME 4:30 IMAGING OPTIONS FLOW COMPENSATION, TAILORED RF, SURFACE COIL INTENSITY CORRECTION, FAST, RESPIRATORY GAITING / TRIGGERING, ZIP 512

11 Table 3. Retroperitoneal evaluation. AX T2 FRFSE BH AXIAL TR TE 90.O ECHO TRAIN 22 BANDWITH FOV 40 SLICE THICKNESS 6.0 SPACING 0.0 FREQ 320 PHASE 192 NEX 1.00 PHASE FOV 0.75 FREQ DIR R/L AUTO CENTER FREQ WATER FLOW COMP DIRECTION FREQ AUTOSHIM PHASE CORRECT PLANE OBLIQUE PULSE SEQ FRFSE XL MODE 2D TIME 1:42 / 0:20 IMAGING OPTIONS FC, VBw, SCIC, TRF, FAST IMAGEN INFERIOR DE ESTA SECUENCIA = IMAGEN SUPERIOR DE AXIAL DE ALTA RESOLUCIÓN Table 4. Seventh edition TNM classification (2010) Primary tumor (T) (9) TX primary tumor cannot be assessed TO no evidence of primary tumor Tis carcinoma in situ: intraepithelial or invasion of lamina propria T1 the tumor invades submucosa T2 the tumor invades muscularis propria T3 tumor invades through the muscularis propia into pericolorectal tissue T4a the tumor penetrates to the surface of the visceral peritoneum T4b the tumor directly invades or is adherent to other organs or structures

12 Fig. 3. Patient with rectal cancer, 62 year-old woman. The extramural depth of the tumor (arrow) determines the T3 subdivision. The arrow indicates the distance between the lateral border of the muscularis propria and the lateral border of the tumor in the T2-weighted high resolution image, axial plane. Fig 4. Rectal cancer patient, 52 year-old man. T2-weighted high resolution image, sagittal plane, shows tumor extension into the peritoneal reflection. It corresponds to T4a tumor staging of the new TNM classification.

13 Table 5. Seventh edition TNM classification (2010) Regional Lymph Nodes (N) (9) NX N0 N1 N1a N1b N1c N2 N2a N2b Regional lymph nodes cannot be assessed No regional lymph node metastasis Metastasis in 1 3 regional lymph nodes Metastasis in one regional lymph node Metastasis in 2 3 regional lymph nodes Tumor deposit(s) in the subserosa, mesentery, or nonperitonealized pericolic or perirectal tissues without regional nodal metastasis Metastasis in four or more regional lymph nodes Metastasis in 4 6 regional lymph nodes Metastasis in seven or more regional lymph nodes Fig. 5. A. Rectal cancer patient, 87 year-old woman. T2-weighted high resolution image, axial plane, showing lymph nodes with irregular borders and mixed signal intensity (arrows). B. Rectal cancer patient, 57 year-old man. T2-weighted high resolution image, axial plane. The arrow indicates a lymph node of mixed signal intensity.

14 Fig. 6. A. Rectal cancer patient, 68 year-old man. The T2-weighted high resolution image, axial plane, displays the presence of extramural vascular invasion. The arrows indicate dilated mesorectal vessels with intermediate signal inside due to tumor extension. B. Rectal cancer patient, 33 year-old man. T2weighted high resolution image, sagittal plane. In this patient the image shows extramural vascular invasion engaging the superior rectal vein by extension of the mucinous tumor.

15 Negative Extramural Vascular Invasion by High-Resolution MRI Scoring 0 Smooth tumor border There are no vessels adjacent to the penetration of the tumor Scoring 1 Lightly-nodular tumor border Without adjacent vessels Scoring 2 Tumor border extends into proximity with vessels, but the vessels are of normal caliber and there is no tumor signal within the vessels.

16 Positive Extramural Vascular Invasion by High-Resolution MRI Scoring 3 Intermediate signal in the vessels, with the vascular edge and caliber mildly dilated Scoring 4 Irregular vessel edge or nodular dilation by tumor signal inside Fig. 7. High-Resolution MRI classification of extramural vascular invasion. Scoring 0-4 (Modified of 16) Table 6. Low rectal tumor staging evaluated by high-resolution MRI (11). 1. Tumor limited to rectal wall without full thickness extension, external muscular layer intact 2. Tumor replacing the muscular layer without extension towards the intersphincteric plane 3. Tumor invading intersphincteric plane or located within 1 mm of levator muscle 4. Tumor invading external sphincter and located within 1 mm and beyond levators with or without adjacent organ involvement

17 Fig. 8. A and B. Patient with low rectal tumor, 54 year-old woman. T2-weighted high resolution MRI images, axial plane, showing involvement of the left anal levator muscle (arrows). Table7. Degree of tumoral regression adapted to the images (11) Complete radiological response: No evidence of treated tumor. Good response (dense fibrosis, tumor not visible: minimal or absent residual disease) Moderate response (>50% fibrosis or mucin and visible intermediate signal) Slight response (small areas of fibrosis or mucin, predominating tumor's presence) No response: intermediate signal intensity, same appearance as original tumor A B Fig. 9. A and B. Rectal cancer patient, 58 year-old man. T2-weighted high resolution MRI images, axial plane, of patient with complete pathological response after neoadyuvant treatment (ypt0n0), showing fibrosis in the rectal wall with extension to the mesorectum. The dense fibrosis results in a significant decrease of rectal lumen.

18 Table 8. High-resolution MRI report for local staging of rectal cancer. Is this the 1 st MRI?: (yes/no) Is post-treatment MRI?: (yes/no) Liver: Retroperitoneum: T Staging: mucinous tumor: (yes/no) extramural depth of tumor invasion: tumor invasion site and morphology: (regular / nodular infiltrate) maximum tumor thickness: tumor dimensions and morphology: polypoidal concentric (annular) stenotic eccentric rectal lumen stenosis: Tumor location and relation with neighbors structures: tumor location in axial plane (hourly signal relation): hour to hour relation with peritoneal reflection: distance to sphincter (upper portion): distance to anal margin: N staging: number, size, lymph node location and relation with the tumor: Mesorectal: positives: negatives: Lateral lymphatic dissemination: positives: negatives: Satellite deposits: Evidence of extramural vascular invasion: (yes/no) scoring (0-4) Circumferential resection margin: free involved Distance to mesorectal fascia: Distance to circumferential resection margin: primary tumor: lymph nodes involved: satellite deposits: extramural vascular invasion: Lower-third tumors: level with or below the distal levator insertion muscularis propia involved: (yes/no) levators: free contact infiltration external sphincter: free contact infiltration MRI staging for low rectal tumors: stage Tumor limited to rectal wall without full thickness extension, external muscular layer intact 2. Tumor replacing the muscular layer without extension towards the intersphincteric plane 3. Tumor invading intersphincteric plane or located within 1 mm of levator muscle 4. Tumor invading external sphincter and located within 1 mm and beyond levators with or without adjacent organ involvement Post-chemoradiotherapy response: grade No response: intermediate signal intensity, same appearance as original tumor 4. Slight response (small areas of fibrosis or mucin, predominating tumor's presence) 3. Moderate response (>50% fibrosis or mucin and visible intermediate signal) 2. Good response (dense fibrosis, tumor not visible: minimal or absent residual disease) 1. Complete radiological response: no evidence of treated tumor. Conclusion: final staging

IMAGING GUIDELINES - COLORECTAL CANCER

IMAGING GUIDELINES - COLORECTAL CANCER IMAGING GUIDELINES - COLORECTAL CANCER DIAGNOSIS The majority of colorectal cancers are diagnosed on colonoscopy, with some being diagnosed on Ba enema, ultrasound or CT. STAGING CT chest, abdomen and

More information

RECTAL CARCINOMA: A DISTANCE APPROACH. Stephanie Nougaret

RECTAL CARCINOMA: A DISTANCE APPROACH. Stephanie Nougaret RECTAL CARCINOMA: A DISTANCE APPROACH Stephanie Nougaret stephanienougaret@free.fr Despite the major improvements that have been made due to total mesorectal excision (TME) management of rectal cancer

More information

Colorectal Pathway Board (Clinical Subgroup): Imaging Guidelines September 2015

Colorectal Pathway Board (Clinical Subgroup): Imaging Guidelines September 2015 Colorectal Pathway Board (Clinical Subgroup): Imaging Guidelines September 2015 1 Contents Page No. 1. Objective 3 2. Imaging Techniques 3 3. Staging of Colorectal Cancer 5 4. Radiological Reporting 6

More information

Disclosure. Acknowledgement. What is the Best Workup for Rectal Cancer Staging: US/MRI/PET? Rectal cancer imaging. None

Disclosure. Acknowledgement. What is the Best Workup for Rectal Cancer Staging: US/MRI/PET? Rectal cancer imaging. None What is the Best Workup for Rectal Cancer Staging: US/MRI/PET? Zhen Jane Wang, MD Assistant Professor in Residence UC SF Department of Radiology Disclosure None Acknowledgement Hueylan Chern, MD, Department

More information

Role of MRI for Staging Rectal Cancer

Role of MRI for Staging Rectal Cancer Role of MRI for Staging Rectal Cancer High-resolution MRI has supplanted endoscopic ultrasound for staging rectal cancer. High-resolution MR images closely match histology and can show details such as

More information

COLORECTAL CANCER STAGING in 2010

COLORECTAL CANCER STAGING in 2010 COLORECTAL CANCER STAGING in 2010 Robert A. Halvorsen, MD, FACR MCV Hospitals / VCU Medical Center Richmond, Virginia I do not have any relevant financial relationships with any commercial interests COLON

More information

Rectal Cancer Cookbook Update. A. JOURET-MOURIN with the collaboration of A Hoorens,P Demetter, G De Hertogh,C Cuvelier and C Sempoux

Rectal Cancer Cookbook Update. A. JOURET-MOURIN with the collaboration of A Hoorens,P Demetter, G De Hertogh,C Cuvelier and C Sempoux Rectal Cancer Cookbook Update A. JOURET-MOURIN with the collaboration of A Hoorens,P Demetter, G De Hertogh,C Cuvelier and C Sempoux Prof Dr A Jouret-Mourin, Department of Pathology, UCL, St Luc, Brussels

More information

8. The polyp in the illustration can be described as (circle all that apply) a. Exophytic b. Pedunculated c. Sessile d. Frank

8. The polyp in the illustration can be described as (circle all that apply) a. Exophytic b. Pedunculated c. Sessile d. Frank Quiz 1 Overview 1. Beginning with the cecum, which is the correct sequence of colon subsites? a. Cecum, ascending, splenic flexure, transverse, hepatic flexure, descending, sigmoid. b. Cecum, ascending,

More information

Colorectal Cancer Structured Pathology Reporting Proforma DD MM YYYY

Colorectal Cancer Structured Pathology Reporting Proforma DD MM YYYY Colorectal Cancer Structured Pathology Reporting Proforma Mandatory questions (i.e. protocol standards) are in bold (e.g. S1.03). Family name Given name(s) Date of birth DD MM YYYY S1.02 Clinical details

More information

Handling & Grossing of Colo-rectal Specimens for Tumours. for Medical Officers in Pathology

Handling & Grossing of Colo-rectal Specimens for Tumours. for Medical Officers in Pathology Handling & Grossing of Colo-rectal Specimens for Tumours for Medical Officers in Pathology Dr Gayana Mahendra Department of Pathology Faculty of Medicine University of Kelaniya Your Role in handling colorectal

More information

Rectal cancer management: a team sport The role of radiology and the multidisciplinary conference

Rectal cancer management: a team sport The role of radiology and the multidisciplinary conference Rectal cancer management: a team sport The role of radiology and the multidisciplinary conference W. Donald Buie MD MSc FRCSC Professor of Surgery and Oncology Department of Surgery University of Calgary

More information

Staging of rectal cancer on MRI: What the surgeons want to know.

Staging of rectal cancer on MRI: What the surgeons want to know. Staging of rectal cancer on MRI: What the surgeons want to know. Poster No.: C-1108 Congress: ECR 2014 Type: Educational Exhibit Authors: G. Ayub, R. Chittal, A. Lowe, A. S. Punekar ; Leeds/, 1 2 1 2 2

More information

L impatto dell imaging sulla definizione della strategia terapeutica

L impatto dell imaging sulla definizione della strategia terapeutica GISCoR L impatto dell imaging sulla definizione della strategia terapeutica M. Galeandro U.C. Radioterapia Oncologica ASMN-IRCCS Reggio Emilia 14 Novembre 2014 Rectal Cancer TNM AJCC-7 th edition 2010

More information

Imaging in gastric cancer

Imaging in gastric cancer Imaging in gastric cancer Gastric cancer remains a deadly disease because of late diagnosis. Adenocarcinoma represents 90% of malignant tumors. Diagnosis is based on endoscopic examination with biopsies.

More information

Colon and Rectum. Protocol revision date: January 2005 Based on AJCC/UICC TNM, 6th edition

Colon and Rectum. Protocol revision date: January 2005 Based on AJCC/UICC TNM, 6th edition Colon and Rectum Protocol applies to all invasive carcinomas of the colon and rectum. Carcinoid tumors, lymphomas, sarcomas, and tumors of the vermiform appendix are excluded. Protocol revision date: January

More information

MRI Rectal Staging Template Revision Summary

MRI Rectal Staging Template Revision Summary MRI Rectal Staging Template 2015 Revision Summary The following changes have been made since the June 2012 release. Formatting Standardized headings were added to the template. These headings are: Clinical

More information

Essentials of Clinical MR, 2 nd edition. 73. Urinary Bladder and Male Pelvis

Essentials of Clinical MR, 2 nd edition. 73. Urinary Bladder and Male Pelvis 73. Urinary Bladder and Male Pelvis Urinary bladder carcinoma is best locally staged with MRI. It is important however to note that a thickened wall (> 5 mm) is a non-specific finding seen in an underfilled

More information

Alison Douglass Gillian Lieberman, MD. November. Colon Cancer. Alison Douglass, Harvard Medical School Year III Gillian Lieberman, MD

Alison Douglass Gillian Lieberman, MD. November. Colon Cancer. Alison Douglass, Harvard Medical School Year III Gillian Lieberman, MD November Colon Cancer Alison Douglass, Harvard Medical School Year III Our Patient Mr. K. is a 67 year old man with no prior medical problems other than hemorrhoids which have caused occasional rectal

More information

MRI in staging of rectal carcinoma

MRI in staging of rectal carcinoma MRI in staging of rectal carcinoma Poster No.: C-0152 Congress: ECR 2015 Type: Scientific Exhibit Authors: J. R. Ramos Rodriguez, M. Atencia Ballesteros, M. D. M. Muñoz Ruiz, A. J. Márquez Moreno, M. D.

More information

11/21/13 CEA: 1.7 WNL

11/21/13 CEA: 1.7 WNL Case Scenario 1 A 70 year-old white male presented to his primary care physician with a recent history of rectal bleeding. He was referred for imaging and a colonoscopy and was found to have adenocarcinoma.

More information

Gastric Cancer Histopathology Reporting Proforma

Gastric Cancer Histopathology Reporting Proforma Gastric Cancer Histopathology Reporting Proforma Mandatory questions (i.e. protocol standards) are in bold (e.g. S1.01). S1.01 Identification Family name Given name(s) Date of birth Sex Male Female Intersex/indeterminate

More information

Staging Colorectal Cancer

Staging Colorectal Cancer Staging Colorectal Cancer CT is recommended as the initial staging scan for colorectal cancer to assess local extent of the disease and to look for metastases to the liver and/or lung Further imaging for

More information

MRI of Rectal Cancer

MRI of Rectal Cancer MRI of Rectal Cancer Arnd-Oliver Schäfer Mathias Langer MRI of Rectal Cancer Clinical Atlas Prof. Dr. Arnd-Oliver Schäfer Department of Diagnostic Radiology Freiburg University Hospital Hugstetter Straße

More information

Gastric Cancer Staging AJCC eighth edition. Duncan McLeod Westmead Hospital, NSW

Gastric Cancer Staging AJCC eighth edition. Duncan McLeod Westmead Hospital, NSW Gastric Cancer Staging AJCC eighth edition Duncan McLeod Westmead Hospital, NSW Summary of changes New clinical stage prognostic groups, ctnm Postneoadjuvant therapy pathologic stage groupings, yptnm -

More information

[A RESEARCH COORDINATOR S GUIDE]

[A RESEARCH COORDINATOR S GUIDE] 2013 COLORECTAL SURGERY GROUP Dr. Carl J. Brown Dr. Ahmer A. Karimuddin Dr. P. Terry Phang Dr. Manoj J. Raval Authored by Jennifer Lee A cartoon about colonoscopies. 1 [A RESEARCH COORDINATOR S GUIDE]

More information

Staging Challenges in Lower GI Cancers. Disclosure of Relevant Financial Relationships. AJCC 8 th edition and CAP protocol updates

Staging Challenges in Lower GI Cancers. Disclosure of Relevant Financial Relationships. AJCC 8 th edition and CAP protocol updates Staging Challenges in Lower GI Cancers Sanjay Kakar, MD University of California, San Francisco March 05, 2017 Disclosure of Relevant Financial Relationships USCAP requires that all planners (Education

More information

TME and autonomic nerve preservation techniques: based on Video and Cadaveric anatomy

TME and autonomic nerve preservation techniques: based on Video and Cadaveric anatomy TME and autonomic nerve preservation techniques: based on Video and Cadaveric anatomy Nam Kyu Kim M.D., Ph.D., FACS, FRCS, FASCRS Professor Department of Surgery Yonsei University College of Medicine Seoul,

More information

RECTAL CANCER CLINICAL CASE PRESENTATION

RECTAL CANCER CLINICAL CASE PRESENTATION RECTAL CANCER CLINICAL CASE PRESENTATION Francesco Sclafani Medical Oncologist, Clinical Research Fellow The Royal Marsden NHS Foundation Trust, London, UK esmo.org Disclosure I have nothing to declare

More information

Carcinoma of the Urinary Bladder Histopathology

Carcinoma of the Urinary Bladder Histopathology Carcinoma of the Urinary Bladder Histopathology Reporting Proforma (Radical & Partial Cystectomy, Cystoprostatectomy) Includes the International Collaboration on Cancer reporting dataset denoted by * Family

More information

A916: rectum: adenocarcinoma

A916: rectum: adenocarcinoma General facts of colorectal cancer The colon has cecum, ascending, transverse, descending and sigmoid colon sections. Cancer can start in any of the r sections or in the rectum. The wall of each of these

More information

Pathohistological Assessment of the Circular Margin of Resection During Total Mesorectal Excision, Conducted on The Malignant Formations of the Rectum

Pathohistological Assessment of the Circular Margin of Resection During Total Mesorectal Excision, Conducted on The Malignant Formations of the Rectum International Journal of Research Studies in Science, Engineering and Technology Volume 4, Issue 5, 2017, PP 17-22 ISSN : 2349-476X http://dx.doi.org/10.22259/ijrsset.0405004 Pathohistological Assessment

More information

A schematic of the rectal probe in contact with the prostate is show in this diagram.

A schematic of the rectal probe in contact with the prostate is show in this diagram. Hello. My name is William Osai. I am a nurse practitioner in the GU Medical Oncology Department at The University of Texas MD Anderson Cancer Center in Houston. Today s presentation is Part 2 of the Overview

More information

Definition of Synoptic Reporting

Definition of Synoptic Reporting Definition of Synoptic Reporting The CAP has developed this list of specific features that define synoptic reporting formatting: 1. All required cancer data from an applicable cancer protocol that are

More information

Current Issues and Controversies in the Management of Rectal Cancer

Current Issues and Controversies in the Management of Rectal Cancer Current Issues and Controversies in the Management of Rectal Cancer Ghazi M. Nsouli MD 11 th Annual Congress of the Lebanese Society of Gastroenterology November 16, 2012 GMN 20121116 1 Staging of rectal

More information

Local staging of colon cancer: the current role of CT

Local staging of colon cancer: the current role of CT Local staging of colon cancer: the current role of CT Poster No.: C-2699 Congress: ECR 2018 Type: Authors: Keywords: DOI: Educational Exhibit A. P. Pissarra, R. R. Domingues Madaleno, C. Sanches, L. Curvo-

More information

CHAPTER 7 Concluding remarks and implications for further research

CHAPTER 7 Concluding remarks and implications for further research CONCLUDING REMARKS AND IMPLICATIONS FOR FURTHER RESEARCH CHAPTER 7 Concluding remarks and implications for further research 111 CHAPTER 7 Molecular staging of large sessile rectal tumors In this thesis,

More information

SEER EOD AND SUMMARY STAGE ABSTRACTORS TRAINING

SEER EOD AND SUMMARY STAGE ABSTRACTORS TRAINING SEER EOD AND SUMMARY STAGE ABSTRACTORS TRAINING OVERVIEW What is SEER EOD Ambiguous Terminology General Guidelines EOD Primary Tumor EOD Regional Nodes EOD Mets Site Specific Data Items (SSDI) SEER Summary

More information

The Role Of The Post-CRT MRI In Assessing Response

The Role Of The Post-CRT MRI In Assessing Response Low Rectal Cancer: Is It Safe To Change The Plane Of Surgery? The Role Of The Post-CRT MRI In Assessing Response Nick Battersby, Mit Dattani, Nick West, Graham Branagan, Mark Gudgeon, Phil Quirke, Paris

More information

I have no financial relationships to disclose. I WILL NOT include discussion of investigational or off-label use of a product in my presentation.

I have no financial relationships to disclose. I WILL NOT include discussion of investigational or off-label use of a product in my presentation. Prostate t Cancer MR Report Disclosure Information Vikas Kundra, M.D, Ph.D. I have no financial relationships to disclose. I WILL NOT include discussion of investigational or off-label use of a g product

More information

MUSCLE - INVASIVE AND METASTATIC BLADDER CANCER

MUSCLE - INVASIVE AND METASTATIC BLADDER CANCER 10 MUSCLE - INVASIVE AND METASTATIC BLADDER CANCER Recommendations from the EAU Working Party on Muscle Invasive and Metastatic Bladder Cancer G. Jakse (chairman), F. Algaba, S. Fossa, A. Stenzl, C. Sternberg

More information

Dr. Anat Ravid Surgical Oncology Lead Erie St. Clair Regional Cancer Program May 1, 2014

Dr. Anat Ravid Surgical Oncology Lead Erie St. Clair Regional Cancer Program May 1, 2014 Preoperative Staging MRI in Rectal Cancer: Where Are We Going in the Pelvis? Dr. Anat Ravid Surgical Oncology Lead Erie St. Clair Regional Cancer Program May 1, 2014 Objectives: How are we looking? Who

More information

COLORECTAL CARCINOMA

COLORECTAL CARCINOMA QUICK REFERENCE FOR HEALTHCARE PROVIDERS MANAGEMENT OF COLORECTAL CARCINOMA Ministry of Health Malaysia Malaysian Society of Colorectal Surgeons Malaysian Society of Gastroenterology & Hepatology Malaysian

More information

LOINC. Clinical information. RCPA code. Record if different to report header Operating surgeon name and contact details. Absent.

LOINC. Clinical information. RCPA code. Record if different to report header Operating surgeon name and contact details. Absent. Complete as narrative or use the structured format below 55752-0 17.02.28593 Clinical information 22027-7 17.02.30001 Record if different to report header Operating surgeon name and contact details 52101004

More information

Case Conference. Craig Morgenthal Department of Surgery Long Island College Hospital

Case Conference. Craig Morgenthal Department of Surgery Long Island College Hospital Case Conference Craig Morgenthal Department of Surgery Long Island College Hospital Neoadjuvant versus Adjuvant Radiation Therapy in Rectal Carcinoma Epidemiology American Cancer Society statistics for

More information

Rectal Cancer: Classic Hits

Rectal Cancer: Classic Hits Rectal Cancer: Classic Hits Charles M. Friel, MD Associate Professor of Surgery Section of Colon and Rectal Surgery University of Virginia September 28, 2016 None Disclosures 1 Objectives Review the Classic

More information

Accuracy of transvaginal ultrasound and magnetic resonance imaging in diagnosis and extension of pelvic endometriosis

Accuracy of transvaginal ultrasound and magnetic resonance imaging in diagnosis and extension of pelvic endometriosis Accuracy of transvaginal ultrasound and magnetic resonance imaging in diagnosis and extension of pelvic endometriosis A.Salem, Kh. Fakhfakh, S. Mehiri, Y. Ben Brahim, F. Ben Amara, H. Rajhi, R. Hamza,

More information

Rectal Cancer Update 2008 The Last 5 cm. Consensus Building

Rectal Cancer Update 2008 The Last 5 cm. Consensus Building Rectal Cancer Update 2008 The Last 5 cm Consensus Building Case Distal Rectal Cancer 65 male physician Rectal mass: 5cm from anal verge, 1cm above sphincter? Imaging choice: CT vs MR vs ERUS? Adjuvant

More information

Tumours of the Oesophagus & Gastro-Oesophageal Junction Histopathology Reporting Proforma

Tumours of the Oesophagus & Gastro-Oesophageal Junction Histopathology Reporting Proforma Tumours of the Oesophagus & Gastro-Oesophageal Junction Histopathology Reporting Proforma Mandatory questions (i.e. protocol standards) are in bold (e.g. S1.01). S1.01 Identification Family name Given

More information

S1.04 PRINCIPAL CLINICIAN G1.01 COMMENTS S2.01 SPECIMEN LABELLED AS G2.01 *SPECIMEN DIMENSIONS (PROSTATE) S2.03 *SEMINAL VESICLES

S1.04 PRINCIPAL CLINICIAN G1.01 COMMENTS S2.01 SPECIMEN LABELLED AS G2.01 *SPECIMEN DIMENSIONS (PROSTATE) S2.03 *SEMINAL VESICLES Prostate Cancer Histopathology Reporting Proforma (Radical Prostatectomy) Includes the International Collaboration on Cancer reporting dataset denoted by * Family name Given name(s) Date of birth Indigenous

More information

AJCC Cancer Staging 8 th Edition

AJCC Cancer Staging 8 th Edition AJCC Cancer Staging 8 th Edition Colon and Rectal Cancer Staging Update Webinar George J Chang, MD, MS Deputy Chair, Department of Surgical Oncology Chief, Colon and Rectal Surgery Professor of Surgical

More information

Seventh Edition Staging 2017 Colorectum. Overview. This webinar is sponsored by. the Centers for Disease Control and Prevention.

Seventh Edition Staging 2017 Colorectum. Overview. This webinar is sponsored by. the Centers for Disease Control and Prevention. Seventh Edition Staging 2017 Colorectum Donna M. Gress, RHIT, CTR Validating science. Improving patient care. No materials in this presentation may be repurposed in print or online without the express

More information

Collaborative Stage for TNM 7 - Revised 06/30/2008 [ Schema ]

Collaborative Stage for TNM 7 - Revised 06/30/2008 [ Schema ] Collaborative Stage for TNM 7 - Revised 06/30/2008 [ Schema ] CS Tumor Size 000 No mass/tumor found 001-988 001-988 millimeters (code exact size in millimeters) 989 989 millimeters or larger 990 Microscopic

More information

Introduction to The Human Body

Introduction to The Human Body 1 Introduction to The Human Body FOCUS: The human organism is often examined at seven structural levels: chemical, organelle, cell, tissue, organ, organ system, and the organism. Anatomy examines the structure

More information

Colon and Rectum 5/1/14

Colon and Rectum 5/1/14 Collecting Cancer Data: Colon and Rectum 2013 2014 NAACCR Webinar Series May 1, 2014 Q&A Please submit all questions concerning webinar content through the Q&A panel. Reminder: If you have participants

More information

MUSCLE-INVASIVE AND METASTATIC BLADDER CANCER

MUSCLE-INVASIVE AND METASTATIC BLADDER CANCER MUSCLE-INVASIVE AND METASTATIC BLADDER CANCER (Text update March 2008) A. Stenzl (chairman), N.C. Cowan, M. De Santis, G. Jakse, M. Kuczyk, A.S. Merseburger, M.J. Ribal, A. Sherif, J.A. Witjes Introduction

More information

Proposed All Wales Vulval Cancer Guidelines. Dr Amanda Tristram

Proposed All Wales Vulval Cancer Guidelines. Dr Amanda Tristram Proposed All Wales Vulval Cancer Guidelines Dr Amanda Tristram Previous FIGO staging FIGO Stage Features TNM Ia Lesion confined to vulva with

More information

NUMERATOR: Reports that include the pt category, the pn category and the histologic grade

NUMERATOR: Reports that include the pt category, the pn category and the histologic grade Quality ID #100 (NQF 0392): Colorectal Cancer Resection Pathology Reporting: pt Category (Primary Tumor) and pn Category (Regional Lymph Nodes) with Histologic Grade National Quality Strategy Domain: Effective

More information

Early Rectal Cancer Surgical options Organ Preservation? Chinna Reddy Colorectal Surgeon Western General, Edinburgh

Early Rectal Cancer Surgical options Organ Preservation? Chinna Reddy Colorectal Surgeon Western General, Edinburgh Early Rectal Cancer Surgical options Organ Preservation? Chinna Reddy Colorectal Surgeon Western General, Edinburgh What is Early rectal cancer? pt1t2n0m0 Predictors for LN involvement Size Depth Intramural

More information

Imaging in rectal cancer with emphasis on local staging with MRI

Imaging in rectal cancer with emphasis on local staging with MRI Imaging in Oncology: Recent dvances Imaging in rectal cancer with emphasis on local staging with MRI Supreeta rya, Deepak Das, Reena Engineer 1, vanish Saklani 2 Departments of Radio Diagnosis, 1 Radiation

More information

Index. Surg Oncol Clin N Am 14 (2005) Note: Page numbers of article titles are in boldface type.

Index. Surg Oncol Clin N Am 14 (2005) Note: Page numbers of article titles are in boldface type. Surg Oncol Clin N Am 14 (2005) 433 439 Index Note: Page numbers of article titles are in boldface type. A Abdominosacral resection, of recurrent rectal cancer, 202 215 Ablative techniques, image-guided,

More information

Radiotherapy for Rectal Cancer. Kevin Palumbo Adelaide Radiotherapy Centre

Radiotherapy for Rectal Cancer. Kevin Palumbo Adelaide Radiotherapy Centre Radiotherapy for Rectal Cancer Kevin Palumbo Adelaide Radiotherapy Centre Overview CRC are common (3 rd commonest cancer) rectal Ca approx 25-30% of all CRC. Presentation PR bleeding: beware attributing

More information

Laparoscopic Resection Of Colon & Rectal Cancers. R Sim Centre for Advanced Laparoscopic Surgery, TTSH

Laparoscopic Resection Of Colon & Rectal Cancers. R Sim Centre for Advanced Laparoscopic Surgery, TTSH Laparoscopic Resection Of Colon & Rectal Cancers R Sim Centre for Advanced Laparoscopic Surgery, TTSH Feasibility and safety Adequacy - same radical surgery as open op. Efficacy short term benefits and

More information

Cover Page. The handle holds various files of this Leiden University dissertation.

Cover Page. The handle   holds various files of this Leiden University dissertation. Cover Page The handle http://hdl.handle.net/887/22038 holds various files of this Leiden University dissertation. Author: Swellengrebel, H.A.M. Title: Challenges in the multimodality treatment of rectal

More information

Staging for Residents, Nurses, and Multidisciplinary Health Care Team

Staging for Residents, Nurses, and Multidisciplinary Health Care Team Staging for Residents, Nurses, and Multidisciplinary Health Care Team Donna M. Gress, RHIT, CTR Validating science. Improving patient care. Learning Objectives Introduce the concept and history of stage

More information

Overview. Collecting Cancer Data: Colon 11/5/2009. Collecting Cancer Data: NAACCR Webinar Series 1. Agenda NAACCR WEBINAR SERIES

Overview. Collecting Cancer Data: Colon 11/5/2009. Collecting Cancer Data: NAACCR Webinar Series 1. Agenda NAACCR WEBINAR SERIES Collecting Cancer Data: Colon 11/5/2009 Collecting Cancer Data: Colon/Rectum/Appendix NAACCR 2009 2010 WEBINAR SERIES Agenda Overview Treatment MP/H Rules CSv2 2 Overview Colon/Rectum/Appendix 2009 2010

More information

AJCC 7 th Edition Staging Disease Site Webinar Colorectum

AJCC 7 th Edition Staging Disease Site Webinar Colorectum AJCC 7 th Edition Staging Disease Site Webinar Colorectum Donna M. Gress, RHIT, CTR Validating science. Improving patient care. This presentation was supported by the Cooperative Agreement Number DP13-1310

More information

7 th Edition Staging. AJCC 7 th Edition Staging. Disease Site Webinar. Colorectum. Overview. This webinar is sponsored by

7 th Edition Staging. AJCC 7 th Edition Staging. Disease Site Webinar. Colorectum. Overview. This webinar is sponsored by AJCC 7 th Edition Staging Colorectum Donna M. Gress, RHIT, CTR Validating science. Improving patient care. This presentation was supported by the Cooperative Agreement Number DP13-1310 from The Centers

More information

Stage: The Language of Cancer

Stage: The Language of Cancer Stage: The Language of Cancer American Joint Committee on Cancer American College of Surgeons Chicago, IL Validating science. Improving patient care. No materials in this presentation may be repurposed

More information

NUMERATOR: Reports that include the pt category, the pn category and the histologic grade

NUMERATOR: Reports that include the pt category, the pn category and the histologic grade Quality ID #100 (NQF 0392): Colorectal Cancer Resection Pathology Reporting: pt Category (Primary Tumor) and pn Category (Regional Lymph Nodes) with Histologic Grade National Quality Strategy Domain: Effective

More information

Lab Monitor Images Dissection of the Abdominal Vasculature + Lower Digestive System

Lab Monitor Images Dissection of the Abdominal Vasculature + Lower Digestive System Lab Monitor Images Dissection of the Abdominal Vasculature + Lower Digestive System Stomach & Duodenum Frontal (AP) View Nasogastric tube 2 1 3 4 Stomach Pylorus Duodenum 1 Duodenum 2 Duodenum 3 Duodenum

More information

CT PET SCANNING for GIT Malignancies A clinician s perspective

CT PET SCANNING for GIT Malignancies A clinician s perspective CT PET SCANNING for GIT Malignancies A clinician s perspective Damon Bizos Head, Surgical Gastroenterology Charlotte Maxeke Johannesburg Academic Hospital Case presentation 54 year old with recent onset

More information

BODY MRI PROTOCOLS 1.5T

BODY MRI PROTOCOLS 1.5T BODY MRI PROTOCOLS 1.5T Table of Contents Non Specific...3-5 Renals.....6-8 Adrenals.....9-11 Pancreas..12-14 Liver 15-17 Liver No Gad.18-21 Liver Eovist..22-24 Liver Iron Quant 25-29 MRCP.30-34 ENTEROGRAPHY.35-38

More information

GUIDELINES ON PROSTATE CANCER

GUIDELINES ON PROSTATE CANCER 10 G. Aus (chairman), C. Abbou, M. Bolla, A. Heidenreich, H-P. Schmid, H. van Poppel, J. Wolff, F. Zattoni Eur Urol 2001;40:97-101 Introduction Cancer of the prostate is now recognized as one of the principal

More information

Introduction. Chapter 1. Structure and Function. Introduction. Anatomy and Physiology Integrated. Anatomy and Physiology Integrated Anatomy

Introduction. Chapter 1. Structure and Function. Introduction. Anatomy and Physiology Integrated. Anatomy and Physiology Integrated Anatomy Introduction Chapter 1 An Introduction to A&P Study strategies crucial for success Attend all lectures, labs, and study sessions Read your lecture and laboratory assignments before going to class or lab

More information

Dana Alrafaiah. - Amani Nofal. - Ahmad Alsalman. 1 P a g e

Dana Alrafaiah. - Amani Nofal. - Ahmad Alsalman. 1 P a g e - 2 - Dana Alrafaiah - Amani Nofal - Ahmad Alsalman 1 P a g e This lecture will discuss five topics as follows: 1- Arrangement of pelvic viscera. 2- Muscles of Pelvis. 3- Blood Supply of pelvis. 4- Nerve

More information

GUIDELINES ON PENILE CANCER

GUIDELINES ON PENILE CANCER GUIDELINES ON PENILE CANCER (Text updated March 2005) G. Pizzocaro (chairman), F. Algaba, S. Horenblas, H. van der Poel, E. Solsona, S. Tana, N. Watkin 58 Penile Cancer Eur Urol 2004;46(1);1-8 Introduction

More information

11/10/2015. Prostate cancer in the U.S. Multi-parametric MRI of Prostate Diagnosis and Treatment Planning. NIH estimates for 2015.

11/10/2015. Prostate cancer in the U.S. Multi-parametric MRI of Prostate Diagnosis and Treatment Planning. NIH estimates for 2015. Multi-parametric MRI of Prostate Diagnosis and Treatment Planning Temel Tirkes, M.D. Associate Professor of Radiology Director, Genitourinary Radiology Indiana University School of Medicine Department

More information

PATHOLOGY GROUP GUIDELINES FOR THE EXAMINATION AND REPORTING OF COLORECTAL CANCER SPECIMENS

PATHOLOGY GROUP GUIDELINES FOR THE EXAMINATION AND REPORTING OF COLORECTAL CANCER SPECIMENS PATHOLOGY GROUP GUIDELINES FOR THE EXAMINATION AND REPORTING OF COLORECTAL CANCER SPECIMENS Produced by: Address: Yorkshire Cancer Network Pathology Group Arthington House, Cookridge Hospital, Hospital

More information

Local Excision for early rectal cancer

Local Excision for early rectal cancer Local Excision for early rectal cancer M. Trompetto, E. Ganio, G. Clerico, A. Realis Luc, RJ Nicholls Colorectal Eporediensis Centre Clinica S. Rita Vercelli Gruppo Policlinico di Monza Mortality Morbidity

More information

Small Intestine. Protocol revision date: January 2005 Based on AJCC/UICC TNM, 6 th edition

Small Intestine. Protocol revision date: January 2005 Based on AJCC/UICC TNM, 6 th edition Small Intestine Protocol applies to all invasive carcinomas of the small intestine, including those with focal endocrine differentiation. Excludes carcinoid tumors, lymphomas, and stromal tumors (sarcomas).

More information

S1.04 Principal clinician. G1.01 Comments. G2.01 *Specimen dimensions (prostate) S2.02 *Seminal vesicles

S1.04 Principal clinician. G1.01 Comments. G2.01 *Specimen dimensions (prostate) S2.02 *Seminal vesicles Prostate Cancer Histopathology Reporting Proforma (Radical Prostatectomy) Includes the International Collaboration on Cancer reporting dataset denoted by * Family name Given name(s) Date of birth Sex Male

More information

A215- Urinary bladder cancer tissues

A215- Urinary bladder cancer tissues A215- Urinary bladder cancer tissues (formalin fixed) For research use only Specifications: No. of cases: 45 Tissue type: Urinary bladder cancer tissues No. of spots: 2 spots from each cancer case (90

More information

ACRIN 6666 Therapeutic Surgery Form

ACRIN 6666 Therapeutic Surgery Form S1 ACRIN 6666 Therapeutic Surgery Form 6666 Instructions: Complete a separate S1 form for each separate area of each breast excised with the intent to treat a cancer (e.g. each lumpectomy or mastectomy).

More information

Update on staging colorectal carcinoma, the 8 th edition AJCC. General overview of staging. When is staging required? 11/1/2017

Update on staging colorectal carcinoma, the 8 th edition AJCC. General overview of staging. When is staging required? 11/1/2017 Update on staging colorectal carcinoma, the 8 th edition AJCC Dale C. Snover, MD November 3, 2017 General overview of staging Reason for uniform staging Requirements to use AJCC manual and/or CAP protocols

More information

TOPICS FOR DISCUSSION

TOPICS FOR DISCUSSION INTERNATIONAL SOCIETY OF UROLOGIC PATHOLOGY PATHOLOGIC STAGING OF SELECT UROLOGIC MALIGNANCIES Mahul B. Amin, MD Professor and Chairman Pathology and Laboratory Medicine Cedars-Sinai Medical Center Los

More information

North of Scotland Cancer Network Clinical Management Guideline for Carcinoma of the Uterine Cervix

North of Scotland Cancer Network Clinical Management Guideline for Carcinoma of the Uterine Cervix THIS DOCUMENT North of Scotland Cancer Network Carcinoma of the Uterine Cervix UNCONTROLLED WHEN PRINTED DOCUMENT CONTROL Prepared by A Kennedy/AG Macdonald/Others Approved by NOT APPROVED Issue date April

More information

AJCC Cancer Staging 8 th Edition. Prostate Chapter 58. Executive Committee, AJCC. Professor and Director, Duke Prostate Center

AJCC Cancer Staging 8 th Edition. Prostate Chapter 58. Executive Committee, AJCC. Professor and Director, Duke Prostate Center AJCC Cancer Staging 8 th Edition Prostate Chapter 58 Judd W Moul, MD, FACS Executive Committee, AJCC Professor and Director, Duke Prostate Center Duke University Durham, North Carolina Validating science.

More information

Question: If in a particular case, there is doubt about the correct T, N or M category, what do you do?

Question: If in a particular case, there is doubt about the correct T, N or M category, what do you do? Exercise 1 Question: If in a particular case, there is doubt about the correct T, N or M category, what do you do? : 1. I mention both categories that are in consideration, e.g. pt1-2 2. I classify as

More information

6/5/2010. Renal vein invasion & Capsule Penetration (T3a) Adrenal Gland involvement (T4 vs. M1) Beyond Gerota s Fascia? (?T4).

6/5/2010. Renal vein invasion & Capsule Penetration (T3a) Adrenal Gland involvement (T4 vs. M1) Beyond Gerota s Fascia? (?T4). GU Cancer Staging: Updates and Challenging Areas 13 th Current Issues in Surgical Pathology San Francisco, CA June 5, 2010 Jeffry P. Simko, PhD, MD Associate Professor Departments of Urology and Anatomic

More information

Current staging of endometrial carcinoma with MR imaging

Current staging of endometrial carcinoma with MR imaging Current staging of endometrial carcinoma with MR imaging Poster No.: C-1436 Congress: ECR 2015 Type: Educational Exhibit Authors: M. Magalhaes, H. Donato, C. B. Marques, P. Gomes, F. Caseiro Alves; Coimbra/PT

More information

Uterine Cervix. Protocol applies to all invasive carcinomas of the cervix.

Uterine Cervix. Protocol applies to all invasive carcinomas of the cervix. Uterine Cervix Protocol applies to all invasive carcinomas of the cervix. Protocol revision date: January 2005 Based on AJCC/UICC TNM, 6 th edition and FIGO 2001 Annual Report Procedures Cytology (No Accompanying

More information

Laparoscopic total mesorectal excision (TME) with electric hook for rectal cancer

Laparoscopic total mesorectal excision (TME) with electric hook for rectal cancer Technical Note Page 1 of 8 Laparoscopic total mesorectal excision (TME) with electric hook for rectal cancer Gong Chen, Rong-Xin Zhang, Zhi-Tao Xiao Department of Colorectal Surgery, Sun Yat-sen University

More information

Restaging Locally Advanced

Restaging Locally Advanced Note: This copy is for your personal non-commercial use only. To order presentation-ready copies for distribution to your colleagues or clients, contact us at www.rsna.org/rsnarights. EDUCATION EXHIBITS

More information

Colon and Rectum. Protocol revision date: January 2005 Based on AJCC/UICC TNM, 6th edition

Colon and Rectum. Protocol revision date: January 2005 Based on AJCC/UICC TNM, 6th edition Colon and Rectum Protocol applies to all invasive carcinomas of the colon and rectum. Carcinoid tumors, lymphomas, sarcomas, and tumors of the vermiform appendix are excluded. Protocol revision date: January

More information

Greater Manchester & Cheshire Guidelines for Pathology Reporting for Oesophageal and Gastric Malignancy

Greater Manchester & Cheshire Guidelines for Pathology Reporting for Oesophageal and Gastric Malignancy Greater Manchester & Cheshire Guidelines for Pathology Reporting for Oesophageal and Gastric Malignancy Authors: Dr Gordon Armstrong, Dr Sue Pritchard 1. General Comments 1.1 Cancer reporting: Biopsies

More information

OFCCR CLINICAL DIAGNOSIS AND TREATMENT FORM

OFCCR CLINICAL DIAGNOSIS AND TREATMENT FORM OFCCR CLINICAL DIAGNOSIS AND TREATMENT FORM Name: _, OFCCR # _ OCGN # _ OCR Group # _ HIN# Sex: MALE FEMALE UNKNOWN Date of Birth: DD MMM YYYY BASELINE DIAGNOSIS & TREATMENT 1. Place of Diagnosis: Name

More information

Carcinoma of the Renal Pelvis and Ureter Histopathology

Carcinoma of the Renal Pelvis and Ureter Histopathology Carcinoma of the Renal Pelvis and Ureter Histopathology Reporting Proforma (NEPHROURETERECTOMY AND URETERECTOMY) Includes the International Collaboration on Cancer reporting dataset denoted by * Family

More information

Early colorectal cancer Quality and rules for a good pathology report Histoprognostic factors

Early colorectal cancer Quality and rules for a good pathology report Histoprognostic factors Early colorectal cancer Quality and rules for a good pathology report Histoprognostic factors Frédéric Bibeau, MD, PhD Pathology department Biopathology unit Institut du Cancer de Montpellier France Quality

More information